Abstract
The advancement of nanotechnology has boosted the development of new and modified medicine in treating various human diseases and disorders, particularly in cardiovascular diseases and cancers, which are the two main death-causing killers globally. Nanomaterials are defined as a material with sizes of 1 and 100 nm. Owing to the diverse properties and types of nanomaterials, there is a huge potential utilising them to modify and improve the current drugs and therapeutic strategies. These include enhancing drug effectiveness, increasing target specificity, improving drug stability and bioavailability, increasing body absorption, and minimising off-target cytotoxicity. To achieve the abovementioned drug activities, the responses of the targeted cells, tissues, organ and subsequently the organ system play important parts. Unquestionably, the drug responses could also largely be affected by the pathophysiology and surrounding micro-environments of the diseased models or organs. Vice versa, the drug payloads may also contribute to the alterations in the routine biological processes of the organs or may render toxicity to the target organ or organ systems. This chapter aims to discuss the current nano-systems used for drug delivery and target specificity as well as to provide insights to improve the drug selectivity, safety profile and therapeutic efficacies. The overview of this chapter is depicted in Fig. 11.1.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abd Elgadir M, Uddin S, Ferdosh S, Adam A, Chowdhury AJK, Sarker ZI (2015) Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review. J Food Drug Anal 23(4):619–629. https://doi.org/10.1016/j.jfda.2014.10.008
Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM et al (2011) Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A 108(42):17450–17455. https://doi.org/10.1073/pnas.1114518108
Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M (2016) Nano vesicular lipid carriers of angiotensin II receptor blocker: anti-hypertensive and skin toxicity study in focus. Artif Cells Nanomed Biotechnol 44(3):1002–1007. https://doi.org/10.3109/21691401.2015.1008509
Alexander A, Agrawal M, Uddin A, Siddique S, Shehata AM, Shaker MA et al (2019) Recent expansions of novel strategies towards the drug targeting into the brain. Int J Nanomedicine 14:5895–5909. https://doi.org/10.2147/IJN.S210876
Ali I, Alsehli M, Scotti L, Scotti MT, Tsai ST, Yu RS et al (2020) Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers (Basel) 12(3):598. https://doi.org/10.3390/polym12030598
Alsehli M (2020) Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: recent advances in drug delivery. Saudi Pharm J 28(3):255–265
Anirudhan TS, Nair SS, Nair AS (2016) Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine. Carbohydr Polym 152:687–698. https://doi.org/10.1016/j.carbpol.2016.06.101
Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71(8):1185–1198. https://doi.org/10.1111/jphp.13098
Awi NJ, Teow SY (2018) Antibody-mediated therapy against HIV/AIDS: where are we standing now? J Pathog 2018:8724549. https://doi.org/10.1155/2018/8724549
Bacchav YG, Mondon K, Kalia YN, Gurny R, Moller M (2011) Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J Control Release 153(2):126–132. https://doi.org/10.1016/j.jconrel.2011.03.003
Baganizi DR, Nyairo E, Duncan SA, Singh SR, Dennis VA (2017) Interleukin-10 conjugation to carboxylated PVP-coated silver nanoparticles for improved stability and therapeutic efficacy. Nanomaterials 7(7):165. https://doi.org/10.3390/nano7070165
Balguri SP, Adelli GR, Majumdar S (2016) Topical ophthalmic liquid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm 109:224–235. https://doi.org/10.1016/j.ejpb.2016.10.015
Barabadi H, Ovais M, Shinwari ZK, Saravanan M (2017) Anticancer green bionanomaterials: present status and future prospects. Green Chem Lett Rev 10(4):285–314. https://doi.org/10.1080/17518253.2017.1385856
Bartneck M, Warzecha KT, Tacke F (2014) Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr 3(6):364–376. https://doi.org/10.3978/j.issn.2304-3881.2014.11.02
Bartneck M, Scheyda KM, Warzecha KT, Rizzo LY, Hittatiya K, Luedde T et al (2015) Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. Biomaterials 37:367–382. https://doi.org/10.1016/j.biomaterials.2014.10.030
Benyettou F, Rezgui R, Ravaux F, Jaber T, Blumer K, Jouiad M et al (2015) Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells. J Mater Chem B 3(36):7237–7245. https://doi.org/10.1039/c5tb00994d
Bhirde AA, Patel S, Sousa AA, Patel V, Molinolo AA, Ji Y et al (2010) Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomedicine (Lond) 5(10):1535–1546. https://doi.org/10.2217/nnm.10.90
Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D et al (2010) Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 9(8):2255–2264. https://doi.org/10.1158/1535-7163.MCT-10-0172
Bose T, Latawiec D, Mondal PP, Mandal S (2014) Overview of nano-drugs characteristics for clinical application: the journey from the entry to the exit point. J Nanopart Res 16(8):25. https://doi.org/10.1007/s11051-014-2527-2527
Brown SD, Nativo P, Smith JA, Stirling D, Edwards PR, Venugopal B et al (2010) Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 132(13):4678–4684. https://doi.org/10.1021/ja908117a
Bruinenberg P, Serisier D, Cipolla D, Blanchard J (2010) Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. Pediatr Pulm 354
Burdusel AC, Gherasim O, Grumezescu AM, Mogoanta L, Ficai A, Andronescu E (2018) Biomedical applications of silver nanoparticles: an up-to-date overview. Nanomaterials 8(9):681. https://doi.org/10.3390/nano8090681
Caster JM, Patel AN, Zhang T, Wang A (2017) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(1):e1416. https://doi.org/10.1002/wnan.1416
Castillo-Santaella T, Ortega-Oller I, Padial-Molina M, O’Valle F, Galindo-Moreno P, Jodar-Reyes AB et al (2019) Formulation, colloidal characterization, and in vitro biological effect of BMP-2 loaded PLGA nanoparticles for bone regeneration. Pharmaceutics 11(8):388. https://doi.org/10.3390/pharmaceutics11080388
Chakraborty A, Jana NR (2017) Vitamin C-conjugated nanoparticle protects cells from oxidative stress at low doses but induces oxidative stress and cell death at high doses. ACS Appl Mater Interfaces 9(48):41807–41817. https://doi.org/10.1021/acsami.7b16055
Chakraborty S, Dlie ZY, Chakraborty S, Roy S, Mukherjee B, Besra SE et al (2020) Aptamer-functionalized drug nanocarrier improves hepatocellular carcinoma toward normal by targeting neoplastic hepatocytes. Mol Ther Nucleic Acids 20:34–49. https://doi.org/10.1016/j.omtn.2020.01.034
Chang M, Yang CS, Huang DM (2011) Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy. ACS Nano 5(8):6156–6163. https://doi.org/10.1021/nn200693a
Chang MY, Yang YJ, Chang CH, Tang AC, Liao WY, Cheng FY et al (2013) Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J Control Release 170(2):287–294. https://doi.org/10.1016/j.jconrel.2013.04.022
Che Nordin MA, Teow SY (2018) Review of current cell-penetrating antibody developments for HIV-1 therapy. Molecules 23(2):335. https://doi.org/10.3390/molecules23020335
Clemens DL, Lee BY, Xue M, Thomas CR, Meng H, Ferris D et al (2012) Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob Agents Chemother 56(5):2535–2545. https://doi.org/10.1128/AAC.06049-11
Cruz E, Kayser V (2019) Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics 13:33–51. https://doi.org/10.2147/BTT.S166310
Deng Y, Zhang X, Shen H, He Q, Wu Z, Liao W et al (2020) Application of the nano-drug delivery system in treatment of cardiovascular diseases. Front Bioeng Biotechnol 7:489. https://doi.org/10.3389/fbioe.2019.00489
Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, Zeb A (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine 12:7291–7309. https://doi.org/10.2147/IJN.S146315
Dostalova S, Cerna T, Hynek D, Koudelkova Z, Vaculovic T, Kopel P et al (2016) Site-directed conjugation of antibodies to apoferritin nanocarrier for targeted drug delivery to prostate cancer cells. ACS Appl Mater Interfaces 8(23):14430–14441. https://doi.org/10.1021/acsami.6b04286
Dou Y, Guo J, Chen Y, Han S, Xu X, Shi Q et al (2016) Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice. J Control Release 235:48–62. https://doi.org/10.1016/j.jconrel.2016.05.049
Dutta T, Jain NK (2007) Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly(propyleneimine) dendrimer. Biochem Biophys Acta 1770(4):681–686. https://doi.org/10.1016/j.bbagen.2006.12.007
Duttagupta DS, Jadhav VM, Kadam VJ (2015) Chitosan: a propitious biopolymer for drug delivery. Curr Drug Deliv 12(4):369–381. https://doi.org/10.2174/1567201812666150310151657
Ernsting MJ, Murakami M, Undzys E, Aman A, Press B, Li S-D (2012) A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases. J Control Release 162(3):575–581
Farooq MU, Novosad V, Rozhkova EA, Wali H, Ali A, Fateh AA et al (2018) Gold nanoparticles-enabled efficient dual delivery of anticancer therapeutics to HeLa cells. Sci Rep 8(1):2907. https://doi.org/10.1038/s41598-018-21331-y
Fathi M, Barar J (2017) Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors. Bioimpacts 7(1):49–57. https://doi.org/10.15171/bi.2017.07
Gao N, Xing C, Wang H, Feng L, Zeng X, Mei L et al (2019) pH-responsive dual drug-loaded nanocarriers based on poly (2-ethyl-2-oxazoline) modified black phosphorus nanosheets for cancer chemo/photothermal therapy. Front Pharmacol 10:270. https://doi.org/10.3389/fphar.2019.00270
Geiger BC, Wang S, Padera RF Jr, Grodzinsky AJ, Hammond PT (2018) Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis. Sci Transl Med 10(469):eaat8800. https://doi.org/10.1126/scitranslmed.aat8800
Gracyzk A, Pawlowska R, Jedrzejcyzk D, Chworos A (2020) Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery. Molecules 25(1):204. https://doi.org/10.3390/molecules25010204
Guerrini L, Alvarez-Puebla RA, Pazos-Perez N (2018) Surface modifications of nanoparticles for stability in biological fluids. Materials (Basel) 11(7):1154. https://doi.org/10.3390/ma11071154
Gunaseelan S, Debrah O, Wan L, Leibowitz MJ, Rabson AB, Stein S, Sinko PJ (2004) Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV bioactivity using a novel protease inhibition assay. Bioconjug Chem 15(6):1322–1333. https://doi.org/10.1021/bc0498875
Guo HH, Feng CL, Zhang WX, Luo ZG, Zhang HJ, Zhang TT et al (2019) Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic disease. Nat Commun 10(1):1981. https://doi.org/10.1038/s41467-019-09852-0
Gupta M, Agrawal U, Vyas SP (2012) Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 9(7):783–804. https://doi.org/10.1517/17425247.2012.686490
Hafeez U, Gan HK, Scott AM (2018) Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. Curr Opin Pharmacol 41:114–121. https://doi.org/10.1016/j.coph.2018.05.010
Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST (2017) Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Adv Drug Deliv Rev 108:25–38. https://doi.org/10.1016/j.addr.2016.04.025
Heister E, Neves V, Tilmaciu C, Lipert K, Beltran VS, Coley HM et al (2009) Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon 47(9):2152–2160. https://doi.org/10.1016/j.carbon.2009.03.057
Hemati Azandaryani A, Kashanian S, Derakhshandeh K (2017) Folate conjugated hybrid nanocarrier for targeted letrozole delivery in breast cancer. Pharm Res 34(12):2798–2808. https://doi.org/10.1007/s11095-017-2260-x
Hu X, Gao Z, Tan H, Zhang L (2019) A pH-responsive multifunctional nanocarrier in the application of chemophotodynamic therapy. J Nanomater 3898564:1–12. https://doi.org/10.1155/2019/3898564
Huo M, Zhang Y, Zhou J, Zou A, Yu D, Wu Y et al (2010) Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharm 394(1–2):162–173. https://doi.org/10.1016/j.ijpharm.2010.05.001
Huong L, Liu J, Gao F, Cheng Q, Lu B, Zheng H et al (2018) A dual-responsive, hyaluronic acid targeted drug delivery system based on hollow mesoporous silica nanoparticles for cancer therapy. J Mater Chem B 6(28):4618–4629. https://doi.org/10.1039/c8tb00989a
Inoue Y, Hibino M, Murata I, Kanamoto I (2017) A nanocarrier skin-targeted drug delivery system using an ascorbic acid derivative. Pharm Res 35(1):1. https://doi.org/10.1007/s11095-017-2311-3
Ishihara T, Kubota T, Choi T, Higaki M (2009) Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate. J Pharmacol Exp Ther 329(2):412–417. https://doi.org/10.1124/jpet.108.150276
Iwaszkiewicz KS, Hua S (2014) Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund’s Adjuvant rodent model of acute inflammatory pain. Pain Physician 17(6):E719–E735
Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM et al (2013) Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci Transl Med 5(209):209ra152. https://doi.org/10.1126/scitranslmed.3006839
Jeon J, Vijayaameswara RN, Byun JH, Heo R, Han HS et al (2016) pH-responsive hyaluronic acid-based nanocarrier for treatment of rheumatoid arthritis. J Nanosci Nanotechnol 16(11):11849–11856. https://doi.org/10.1166/jnn.2016.13606
Ji M, Qiu X, Hou L, Huang S, Li Y, Liu Y et al (2018) Construction and application of a liver cancer-targeting drug delivery system based on core–shell gold nanocages. Int J Nanomedicine 13:1773–1789. https://doi.org/10.2147/IJN.S151043
Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z et al (2012) Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33(5):1573–1582. https://doi.org/10.1016/j.biomaterials.2011.10.075
Kamaly N, He JC, Ausiello DA, Farokhzad OC (2016) Nanomedicines for renal disease: current status and future applications. Nat Rev Nephrol 12(12):738–753. https://doi.org/10.1038/nrneph.2016.156
Kang XQ, Shu GF, Jiang SP, Xu XL, Qi J, Jin FY et al (2019) Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified β-Ga2O3:Cr3+ nanoparticles. Theranostics 9(10):2739–2753. https://doi.org/10.7150/thno.33452
Kaur A, Kumar R (2019) Enhanced bactericidal efficacy of polymer stabilized silver nanoparticles in conjugation with different classes of antibiotics. RSC Adv 9(2):1095–1105. https://doi.org/10.1039/C8RA07980C
Kim D, Jeong YY, Jon S (2010) A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4(7):3689–3696. https://doi.org/10.1021/nn901877h
Krishnan V, Xu X, Barwe SP, Yang X, Czymmek K, Waldman SA et al (2013) Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine. Mol Pharm 10(6):2199–2210. https://doi.org/10.1021/mp300350e
Lakhani P, Patil A, Majumdar S (2018) Recent advances in topical nano drug-delivery systems for the anterior ocular segment. Ther Deliv 9(2):137–153. https://doi.org/10.4155/tde-2017-0088
Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K (2009) Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med 234(10):1244–1252. https://doi.org/10.3181/0901-RM-8
Lee EA, Balakrishnan P, Song CK, Choi JH, Noh GY, Park CG et al (2010) Microemulsion-based hydrogel formulation of itraconazole for topical delivery. J Pharm Investig 40(5):305–311. https://doi.org/10.4333/KPS.2010.40.5.305
Lee KX, Shameli K, Mohamed SE, Yew YP, Isa M, Yap HY et al (2019) Bio-mediated synthesis and characterisation of silver nanocarrier, and its potent anticancer action. Nanomaterials 9(10):1423. https://doi.org/10.3390/nano9101423
Lee KX, Shameli K, Yew YP, Teow SY, Jahangirian H, Rafiee-Moghaddam R et al (2020) Recent developments in the facile bio-synthesis of gold nanoparticles (AuNPs) and their biomedical applications. Int J Nanomedicine 15:275–300. https://doi.org/10.2147/IJN.S233789
Li J, Cai C, Li J, Li J, Li J, Sun T et al (2018) Chitosan-based nanomaterials for drug delivery. Molecules 23(10):2661. https://doi.org/10.3390/molecules23102661
Lombardo D, Kiselev MA, Caccamo MT (2019) Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater 2019(12):1–26. https://doi.org/10.1155/2019/3702518
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3(5):703–717. https://doi.org/10.2217/17435889.3.5.703
Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K et al (2006) Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 19(4):190–197. https://doi.org/10.1159/000093114
Maranhao RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares DMMD et al (2017) Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats. Int J Nanomedicine 12:3767–3784. https://doi.org/10.2147/IJN.S129324
Matsuo Y, Ishihara T, Ishizaki J, Miyamoto K, Higaki M, Yamashita N (2009) Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 260(1):33–38. https://doi.org/10.1016/j.cellimm.2009.07.004
Mi P, Cabral H, Kataoka K (2020) Ligand-installed nanocarriers toward precision therapy. Adv Mater 32(13):1902604. https://doi.org/10.1002/adma.201902604
Mudshinge SR, Deore AB, Patil S, Bhalgat CM (2011) Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J 19(3):129–141. https://doi.org/10.1016/j.jsps.2011.04.001
Nance E, Zhang C, Shih TY, Xu Q, Schuster BS, Hanes J (2014) Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration. ACS Nano 8(10):10655–10664. https://doi.org/10.1021/nn504210g
Nashaat D, Elsabahy M, El-Sherif T, Hamad MA, El-Gindy GA, Ibrahim EH (2019) Development and in vivo evaluation of chitosan nanoparticles for the oral delivery of albumin. Pharm Dev Technol 24(3):329–337. https://doi.org/10.1080/10837450.2018.1479867
Naz M, Nasiri N, Ikram M, Nafees M, Qureshi MZ, Ali S et al (2017) Eco-friendly biosynthesis, anticancer drug loading and cytotoxic effect of capped Ag-nanoparticles against breast cancer. Appl Nanosci 7(8):793–802. https://doi.org/10.1007/s13204-017-0615-6
Nelemans LC, Gurevich L (2020) Drug delivery with polymeric nanocarriers-cellular uptake mechanisms. Materials (Basel) 13(2):366. https://doi.org/10.3390/ma13020366
Oduk Y, Zhu W, Kannappan R, Zhao M, Borovjagin AV, Oparil S et al (2018) VEGF nanoparticles repair the heart after myocardial infarction. Am J Physiol Heart Circ Physiol 314(2):H278–H284. https://doi.org/10.1152/ajpheart.00471.2017
Ogunsona EO, Muthuraj R, Ojogbo E, Valerio O, Mekonnen TH (2020) Engineered nanomaterials for antimicrobial applications: a review. Appl Mater Today 18:1–32. https://doi.org/10.1016/j.apmt.2019.100473
Okusanya OO, Bhavnani SM, Hammel J, Minic P, Dupont LJ, Forrest A et al (2009) Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother 53(9):3847–3854. https://doi.org/10.1128/AAC.00872-08
Otterson GA, Villalona-Calero MA, William H, Pan X, Ellerton JA, Gettinger SN (2010) Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin Cancer Res 16(8):2466–2473. https://doi.org/10.1158/1078-0432.CCR-09-3015
Pacheco I, Buzea C (2018) Metal nanoparticles and their toxicity. In: Thota S, Crans DC (eds) Metal nanoparticles: synthesis and applications in pharmaceutical sciences. Wiley, Hoboken, NJ, p 203
Parodi A, Corbo C, Cevenini A, Molinaro R, Palomba R, Pandolfi L et al (2015) Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers. Nanomedicine (Lond) 10(12):1923–1940. https://doi.org/10.2217/nnm.15.39
Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG (2011) Investigating effect of microemulsion components: in vitro permeation of ketoconazole. Pharm Dev Technol 16(3):250–258. https://doi.org/10.3109/10837451003610845
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MP, Acosta-Terres LS et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):71. https://doi.org/10.1186/s12951-018-0392-8
Pechanova O, Barta A, Koneracka M, Zavisova V, Kubovcikova M, Klimentova J et al (2019) Protective effects of nanoparticle-loaded aliskiren on cardiovascular system in spontaneously hypertensive rats. Molecules 24(15):2710. https://doi.org/10.3390/molecules24152710
Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G et al (2007) Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res 67(7):2938–2943. https://doi.org/10.1158/0008-5472.CAN-06-4535
Qin X, Li Y (2020) Strategies to design and synthesize polymer-based stimuli-responsive drug-delivery nanosystems. ChemBioChem 21:1236–1253. https://doi.org/10.1002/cbic.201900550
Qumbar M, Ameeduzzafar, Imam SS, Ali J, Ali A (2017) Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomed Pharmacother 93:255–266. https://doi.org/10.1016/j.biopha.2017.06.043
Ranjan A, Pothayee N, Seleem MN, Sriranganathan N, Kasimanickam R, Makris M et al (2009) In vitro trafficking and efficacy of core-shell nanostructures for treating intracellular Salmonella infections. Antimicrob Agents Chemother 53(9):3985–3988. https://doi.org/10.1128/AAC.00009-09
Reinholz J, Landfester K, Mailander V (2018) The challenges of oral drug delivery via nanocarriers. Drug Deliv 25(1):1694–1705. https://doi.org/10.1080/10717544.2018.1501119
Roome T, Aziz S, Razzak A, Aslam Z, Lubna, Jamali KS et al (2019) Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: novel suppressors of toll-like receptors -2 and -4. Biomed Pharmacother 112:108624. https://doi.org/10.1016/j.biopha.2019.108624
Sahib MN, Darwis Y, Peh KK, Abdulameer SA, Tan YT (2011) Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Int J Nanomedicine 6:2351–2366. https://doi.org/10.2147/IJN.S25363
Salmaso S, Pappalardo JS, Sawant RR, Musacchio T, Rockwell K, Caliceti P et al (2009) Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers. Bioconjug Chem 20(12):2348–2355. https://doi.org/10.1021/bc900369d
Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235:34–47. https://doi.org/10.1016/j.jconrel.2016.05.044
Scott RC, Rosano JM, Ivanov Z, Wang B, Chong PL, Issekutz AC et al (2009) Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 23:3361–3367. https://doi.org/10.1096/fj.08-127373
Sharma S, Kotamraju VR, Molder T, Tobi A, Teesalu T, Ruoslahti E (2017) Tumor-penetrating nanosystem strongly suppresses breast tumor growth. Nano Lett 17(3):1356–1364. https://doi.org/10.1021/acs.nanolett.6b03815
Singh AP, Biswas A, Shukla A, Maiti P (2019) Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles. Signal Transduct Target Ther 4:33. https://doi.org/10.1038/s41392-019-0068-3
Slobbe L, Boersma E, Rijnders BJ (2008) Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial. Pulm Pharmacol Ther 21(6):855–859. https://doi.org/10.1016/j.pupt.2008.09.001
Soe ZC, Kwon JB, Thapa RK, Ou W, Nguyen HT, Gautam M et al (2019) Transferrin-conjugated polymeric nanoparticles for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast cancer cells. Pharmaceutics 11(2):63. https://doi.org/10.3390/pharmaceutics11020063
Solaro R, Chiellini F, Battisti A (2010) Targeted delivery of protein drugs by nanocarriers. Materials (Basel) 3(3):1928–1980. https://doi.org/10.3390/ma3031928
Su S, Kang PM (2020) Systemic review of biodegradable nanomaterials in nanomedicine. Nanomaterials (Basel) 10(4):656. https://doi.org/10.3390/nano10040656
Tan S, Wang G (2018) Lung cancer targeted therapy: folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Biomed Pharmacother 102:55–63. https://doi.org/10.1016/j.biopha.2018.03.046
Teow SY, Wong MMT, Yap HY, Peh SC, Shameli K (2018) Bactericidal properties of plants-derived metal and metal oxide nanoparticles (NPs). Molecules 23(6):1366. https://doi.org/10.3390/molecules23061366
Tesauro D, Accardo A, Diaferia C, Milano V, Guillon J, Ronga L et al (2019) Peptide-based drug delivery systems in biotechnological applications: recent advances and perspectives. Molecules 24(2):351. https://doi.org/10.3390/molecules24020351
Tian G, Pan R, Zhang B, Qu M, Lian B, Jiang H et al (2019) Liver-targeted combination therapy basing on glycyrrhizic acid-modified DSPE-PEG-PEI nanoparticles for co-delivery of doxorubicin and Bcl-2 siRNA. Front Pharmacol 10:4. https://doi.org/10.3389/fphar.2019.00004
Tripathi K, Driskell JD (2018) Quantifying bound and active antibodies conjugated to gold nanoparticles: a comprehensive and robust approach to evaluate immobilization chemistry. ACS Omega 3(7):8253–8259. https://doi.org/10.1021/acsomega.8b00591
Tronino D, Offerta A, Ostacolo C, Russo R, De Caro C, Calignano A et al (2016) Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo. Colloids Surf B Biointerfaces 141:311–317. https://doi.org/10.1016/j.colsurfb.2016.01.058
Tseng CL, Su WY, Yen KC, Yang C, Lin FH (2009) The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 30(20):3476–3485. https://doi.org/10.1016/j.biomaterials.2009.03.010
van Rijt SH, Bein T, Meiners S (2014) Medical nanoparticles for next generation drug delivery to the lungs. Eur Respir J 44(3):765–774. https://doi.org/10.1183/09031936.00212813
Ventola CL (2017) Progress in nanomedicine: approved and investigational nanodrugs. Pharm Ther 42(12):742–755
Vieira DB, Gamarra LF (2016) Advances in the use of nanocarriers for cancer diagnosis and treatment. Einstein (Sao Paulo) 14(1):99–103. https://doi.org/10.1590/S1679-45082016RB3475
Vij N, Min T, Marasigan R, Belcher CN, Mazur S, Ding H et al (2010) Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnol 8:22. https://doi.org/10.1186/1477-3155-8-22
Vijayakameswara Rao N, Ko H, Lee J, Park JH (2018) Recent progress and advances in stimuli-responsive polymers for cancer therapy. Front Bioeng Biotechnol 6:110. https://doi.org/10.3389/fbioe.2018.00110
Vogt A, Wischke C, Neffe AT, Ma N, Alxiev U, Lendlein A (2016) Nanocarriers for drug delivery into and through the skin – do existing technologies match clinical challenges? J Control Release 242:3–15. https://doi.org/10.1016/j.jconrel.2016.07.027
Wacker MG, Proykova A, Santos GML (2016) Dealing with nanosafety around the globe—regulation vs. innovation. Int J Pharm 509(1–2):95–106. https://doi.org/10.1016/j.ijpharm.2016.05.015
Wan L, Zhang X, Gunaseelan S, Pooyan S, Debrah O, Leibowitz MJ et al (2006) Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nanopeptide and saquinavir demonstrate combined anti-HIV effects. AIDS Res Ther 3:12. https://doi.org/10.1186/1742-6405-3-12
Wang B, He X, Zhang Z, Zhao Y, Feng W (2013) Metabolism of nanomaterials in vivo: blood circulation and organ clearance. Acc Chem Res 46(3):761–769. https://doi.org/10.1021/ar2003336
Wang D, Zhou Y, Li X, Qu X, Deng Y, Wang Z et al (2017) Mechanisms of pH-sensitivity and cellular internalization of PEOz-b-PLA micelles with varied hydrophilic/hydrophobic ratios and intracellular trafficking routes and fate of the copolymer. ACS Appl Mater Interfaces 9(8):6916–6930. https://doi.org/10.1021/acsami.6b16376
Wang D, Huang H, Zhou M, Lu H, Chen J, Chang YT et al (2019a) A thermoresponsive nanocarrier for mitochondria-targeted drug delivery. Chem Commun 55(28):4051–4054. https://doi.org/10.1039/c9cc00603f
Wang D, Li X, Li X, Kang A, Sun L, Sun M et al (2019b) Magnetic and pH dual-responsive nanoparticles for synergistic drug-resistant breast cancer chemo/photodynamic therapy. Int J Nanomedicine 14:7665–7679. https://doi.org/10.2147/IJN.S214377
Wei L, Lu B, Cui L, Peng X, Wu J, Li D et al (2017) Folate-conjugated pH-responsive nanocarrier designed for active tumor targeting and controlled release of doxorubicin. Front Mater Sci 11:328–343. https://doi.org/10.1007/s11706-017-0401-0
Wittgen BP, Kunst PW, van der Born K, van Wijk AW, Perkins W, Pilkiewicz FG et al (2007) Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res 13(8):2414–2421. https://doi.org/10.1158/1078-0432
Wohlfart S, Khalansky AS, Gelperina S, Maksimenko O, Bernreuther C, Glatzel M et al (2011) Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One 6(5):e19121. https://doi.org/10.1371/journal.pone.0019121
Wu CH, Lan CH, Wu KL, Wu YM, Jane WN, Hsiao M et al (2018a) Hepatocellular carcinoma-targeted nanoparticles for cancer therapy. Int J Oncol 52(2):389–401. https://doi.org/10.3892/ijo.2017.4205
Wu J, Yuan J, Ye B, Wu Y, Xu Z, Chen J et al (2018b) Dual-responsive core crosslinking glycopolymer-drug conjugates nanoparticles for precise hepatocarcinoma therapy. Front Pharmacol 9:663. https://doi.org/10.3389/fphar.2018.00663
Xiao L, Xiong X, Sun X, Zhu Y, Yang H, Chen H et al (2011) Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 32(22):5148–5157. https://doi.org/10.1016/j.biomaterials.2011.03.071
Xiao Z, Levy-Nissenbaum E, Alexis F, Luptak A, Teply BA, Chan JM et al (2012) Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 6(1):696–704. https://doi.org/10.1021/nn204165v
Xu X, Shan GR, Pan P (2016) Controlled co-delivery of hydrophilic and hydrophobic drugs from thermosensitive and crystallizable copolymer nanoparticles. J Appl Polym Sci 133(42):44132. https://doi.org/10.1002/app.44132
Xu S, Cui F, Huang D, Zhang D, Zhu A, Sun X et al (2018) PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. Int J Nanomedicine 14:17–32. https://doi.org/10.2147/IJN.S175340
Yahyaei B, Pourali P (2019) One step conjugation of some chemotherapeutic drugs to the biologically produced gold nanoparticles and assessment of their anticancer effects. Sci Rep 9(1):10242. https://doi.org/10.1038/s41598-019-46602-0
Yang J, Hou Y, Ji G, Song Z, Liu Y, Dai G et al (2014) Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats. Eur J Pharm Sci 52:180–190. https://doi.org/10.1016/j.ejps.2013.11.017
Yang Y, Qin Z, Zeng W, Yang T, Cao Y, Mei X et al (2017) Toxicity assessment of nanoparticles in various systems and organs. Nanotechnol Rev 6(3):279–289. https://doi.org/10.1515/ntrev-2016-0047
Yao S, Li L, Su XT, Wang K, Lu ZJ, Yuan CZ et al (2018) Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. J Exp Clin Cancer 37(1):29. https://doi.org/10.1186/s13046-018-0700-z
Yao Y, Zang Y, Qu J, Tang M, Zhang T (2019) The toxicity of metallic nanoparticles on liver: the subcellular damages, mechanisms, and outcomes. Int J Nanomedicine 14:8787–8804. https://doi.org/10.2147/IJN.S212907
Zhang XX, Eden HS, Chen X (2012a) Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release 159(1):2–13. https://doi.org/10.1021/ar2000056
Zhang P, Hu L, Yin Q, Zhang Z, Feng L, Li Y (2012b) Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J Control Release 159(3):429–434. https://doi.org/10.1016/j.jconrel.2012.01.031
Zhang YT, Wu ZH, Zhang K, Zhao JH, Ye BN, Feng NP (2014) An in vitro and in vivo comparison of solid and liquid-oil cores in transdermal aconitine nanocarriers. J Pharm Sci 103(11):3602–3610. https://doi.org/10.1002/jps.24152
Zhang M, He J, Jiang C, Zhang W, Yang Y, Wang Z et al (2017) Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy. Int J Nanomedicine 12:533–558. https://doi.org/10.2147/IJN.S124252
Zhang S, Guo N, Wan G, Zhang T, Li C, Wang Y et al (2019) pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. J Nanobiotechnol 17:109. https://doi.org/10.1186/s12951-019-0540-9
Zhang P, Yang H, Shen W, Liu W, Che L, Xiao C (2020) Hypoxia-responsive polypeptide nanoparticles loaded with doxorubicin for breast cancer therapy. ACS Biomater Sci Eng 6(4):2167–2174. https://doi.org/10.1021/acsbiomaterials.0c00125
Zheng D, Giljohann DA, Chen DL, Massich MD, Wang XQ, Iordanov H et al (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci U S A 109(30):11975–11980. https://doi.org/10.1073/pnas.1118425109
Zhou HF, Hu G, Wickline SA, Lanza GM, Pham CT (2010) Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine 5(7):1065–1074. https://doi.org/10.2217/nnm.10.78
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pang, SW., Soon, M.LK., Shameli, K., Janarthanan, P., Teow, SY. (2021). Delivery of Drug Payloads to Organs and Organ-Systems. In: Arivarasan, V.K., Loganathan, K., Janarthanan, P. (eds) Nanotechnology in Medicine. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-61021-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-61021-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-61020-3
Online ISBN: 978-3-030-61021-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)